Business
Annual Report and Notice of AGM
Annual Report and Notice of AGM.
About this update from Advanced Medical Solutions Group Plc
[{"type":"text","content":"\n \nRNS Number : 1316X Advanced Medical Solutions Grp PLC 03 May 2016 \n\n3 May 2016\nAdvanced Medical Solutions Group plc\n(\"AMS\" or the \"Group\")\n \nAnnual Report and Accounts for the year ended\n31 December 2015 and Notice of AGM\n \nWinsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, is pleased to announce that in accordance with AIM Rules 20 and 26, the Annual Report and Financial Statements for the year ended 31 December 2015 were posted to shareholders today and are available on the Investor Relations section of the Company's website http://www.admedsol.com/Investor-Relations \n \nThe notice of meeting convening the Annual General Meeting of the Company, which will be held on 2 June 2016 at 11 a.m. at the offices of Investec Bank plc, 2 Gresham Street, London, EC2V 7QP, was also posted to shareholders today and is available on the Company's website.\n \n- Ends -\n \nFor further information, please visit www.admedsol.com or contact:\n \n\n\n\n\nAdvanced Medical Solutions Group plc\n\n\nTel: +44 (0) 1606 545508\n\n\n\n\nChris Meredith, Chief Executive Officer\nMary Tavener, Group Finance Director\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nConsilium Strategic Communications\n\n\nTel: +44 (0) 20 3709 5700\n\n\n\n\nMary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nInvestec Bank PLC (NOMAD & Broker)\n\n\nTel: +44 (0) 20 7597 5970\n\n\n\n\nGary Clarence / Daniel Adams / Patrick Robb\n\n\n\n\n\n\n\n \n \nAbout Advanced Medical Solutions Group plc \nAMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.\nAMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multina...